Aptevo Therapeutics Statistics
Total Valuation
APVO has a market cap or net worth of $2.39 million. The enterprise value is -$930,822.
Important Dates
The next estimated earnings date is Wednesday, May 7, 2025, before market open.
Earnings Date | May 7, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
APVO has 3.22 million shares outstanding.
Current Share Class | 3.22M |
Shares Outstanding | 3.22M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | +186.34% |
Owned by Insiders (%) | 0.01% |
Owned by Institutions (%) | 7.75% |
Float | 2.42M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 0.23 |
P/TBV Ratio | 0.50 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.72, with a Debt / Equity ratio of 1.14.
Current Ratio | 1.72 |
Quick Ratio | 1.40 |
Debt / Equity | 1.14 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -284.28% and return on invested capital (ROIC) is -110.74%.
Return on Equity (ROE) | -284.28% |
Return on Assets (ROA) | -76.06% |
Return on Invested Capital (ROIC) | -110.74% |
Return on Capital Employed (ROCE) | -262.17% |
Revenue Per Employee | n/a |
Profits Per Employee | -$652,162 |
Employee Count | 37 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -97.18% in the last 52 weeks. The beta is 5.75, so APVO's price volatility has been higher than the market average.
Beta (5Y) | 5.75 |
52-Week Price Change | -97.18% |
50-Day Moving Average | 2.22 |
200-Day Moving Average | 7.56 |
Relative Strength Index (RSI) | 31.81 |
Average Volume (20 Days) | 8,697,065 |
Short Selling Information
The latest short interest is 386,507, so 11.99% of the outstanding shares have been sold short.
Short Interest | 386,507 |
Short Previous Month | 120,620 |
Short % of Shares Out | 11.99% |
Short % of Float | 15.95% |
Short Ratio (days to cover) | 4.92 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -24.60M |
Pretax Income | -24.95M |
Net Income | -24.13M |
EBITDA | -24.25M |
EBIT | -24.60M |
Earnings Per Share (EPS) | -$87.38 |
Full Income Statement Balance Sheet
The company has $8.71 million in cash and $5.40 million in debt, giving a net cash position of $3.32 million or $1.03 per share.
Cash & Cash Equivalents | 8.71M |
Total Debt | 5.40M |
Net Cash | 3.32M |
Net Cash Per Share | $1.03 |
Equity (Book Value) | 4.76M |
Book Value Per Share | 3.26 |
Working Capital | 4.45M |
Full Balance Sheet Cash Flow
Operating Cash Flow | -23.79M |
Capital Expenditures | n/a |
Free Cash Flow | -23.79M |
FCF Per Share | -$7.38 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
APVO does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | n/a |
Shareholder Yield | n/a |
Earnings Yield | -1,011.66% |
FCF Yield | -997.20% |
Analyst Forecast
The average price target for APVO is $296.00, which is 39,900.00% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $296.00 |
Price Target Difference | 39,900.00% |
Analyst Consensus | Strong Buy |
Analyst Count | 1 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Stock Splits
The last stock split was on December 4, 2024. It was a reverse split with a ratio of 0.027027:1.
Last Split Date | Dec 4, 2024 |
Split Type | Reverse |
Split Ratio | 0.027027:1 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 1 |